AnaSpec, a leading US provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions, has established a new facility dedicated to GMP manufacturing in response to increased demand for GMP peptide production.
Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5,000sq ft of dedicated GMP space, including two class 10,000 clean rooms.
Dr Frank Hong, AnaSpec chief executive, said: ‘The expansion of our dedicated GMP manufacturing facilities will allow us to more fully address the stringent requirements of our customers.’
AnaSpec offers GMP peptides in milligram to kilogram quantities. Optimised for bulk API manufacturing, AnaSpec’s GMP peptide services offer >98% purity peptides with QC product release testing, stability studies, and full documentation for drug master files.
With a vision for innovation through synergy, the company focuses on the integration of three core technologies: peptides, detection reagents (including both fluorescent dyes, antibodies, and assay kits), and combinatorial chemistry.
